Cosmo Pharmaceuticals N.V. (VIE:COPN)

Market Cap	1.53B +33.7%
Revenue (ttm)	104.17M -61.0%
Net Income	-3.61M
EPS	-0.23
Shares Out	n/a
PE Ratio	n/a
Forward PE	1,239.62
Dividend	2.10 (2.00%)
Ex-Dividend Date	Apr 24, 2026

Volume	n/a
Average Volume	21
Open	93.50
Previous Close	96.50
Day's Range	93.50 - 94.00
52-Week Range	44.80 - 141.00
Beta	n/a
RSI	26.05
Earnings Date	Mar 9, 2026

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cor...

• Industry: Pharmaceutical Preparations
• Founded: 1997
• Employees: 332
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: COPN